- $24.49m
- $23.21m
- $18.59m
- 63
- 29
- 69
- 53
Annual income statement for Paid, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12.9 | 14.9 | 16.6 | 16.6 | 18.6 |
| Cost of Revenue | |||||
| Gross Profit | 3.11 | 3.45 | 3.69 | 3.79 | 4.07 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 15.1 | 15.4 | 16.5 | 17.2 | 19.1 |
| Operating Profit | -2.13 | -0.49 | 0.059 | -0.588 | -0.493 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.11 | -0.49 | 0.196 | 0.261 | 0.723 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.23 | -0.697 | 0.652 | 0.353 | 0.764 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.23 | -0.697 | 0.652 | 0.353 | 0.764 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.26 | -0.697 | 0.652 | 0.353 | 0.764 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.413 | -0.094 | 0.084 | 0.044 | 0.095 |